Increased VEGF expression has been associated with aggressiveness of the tumor and poorer prognosis in patients with uterine cancer, ovarian cancer [37], breast cancer [37–39], gastric cancer [40], melanoma [41], head and neck cancer [37], and non-small cell lung cancer [38]. Here, VEGFA is linked to head and neck cancer.